APA (7th ed.) Citation

Kanacher, T., Sjögren, E., Korell, J., Plan, E. L., Gómez-Mantilla, J. D., & Ince, I. (2025). Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption. Pharmaceutics, 17(3), 314. https://doi.org/10.3390/pharmaceutics17030314

Chicago Style (17th ed.) Citation

Kanacher, Tobias, Erik Sjögren, Julia Korell, Elodie L. Plan, Jose David Gómez-Mantilla, and Ibrahim Ince. "Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption." Pharmaceutics 17, no. 3 (2025): 314. https://doi.org/10.3390/pharmaceutics17030314.

MLA (9th ed.) Citation

Kanacher, Tobias, et al. "Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption." Pharmaceutics, vol. 17, no. 3, 2025, p. 314, https://doi.org/10.3390/pharmaceutics17030314.